Literature DB >> 15650225

Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.

Sara Akerström1, Mehrdad Mousavi-Jazi, Jonas Klingström, Mikael Leijon, Ake Lundkvist, Ali Mirazimi.   

Abstract

Nitric oxide (NO) is an important signaling molecule between cells which has been shown to have an inhibitory effect on some virus infections. The purpose of this study was to examine whether NO inhibits the replication cycle of the severe acute respiratory syndrome coronavirus (SARS CoV) in vitro. We found that an organic NO donor, S-nitroso-N-acetylpenicillamine, significantly inhibited the replication cycle of SARS CoV in a concentration-dependent manner. We also show here that NO inhibits viral protein and RNA synthesis. Furthermore, we demonstrate that NO generated by inducible nitric oxide synthase, an enzyme that produces NO, inhibits the SARS CoV replication cycle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650225      PMCID: PMC544093          DOI: 10.1128/JVI.79.3.1966-1969.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

Review 1.  Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization.

Authors:  J L Boucher; C Moali; J P Tenu
Journal:  Cell Mol Life Sci       Date:  1999-07       Impact factor: 9.261

2.  Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus.

Authors:  T E Lane; A D Paoletti; M J Buchmeier
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication.

Authors:  Y L Lin; Y L Huang; S H Ma; C T Yeh; S Y Chiou; L K Chen; C L Liao
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Inhibition of influenza virus replication by nitric oxide.

Authors:  G F Rimmelzwaan; M M Baars; P de Lijster; R A Fouchier; A D Osterhaus
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo.

Authors:  K Akarid; M Sinet; B Desforges; M A Gougerot-Pocidalo
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Respiratory nitric oxide levels in experimental human influenza.

Authors:  A W Murphy; T A Platts-Mills; M Lobo; F Hayden
Journal:  Chest       Date:  1998-08       Impact factor: 9.410

7.  Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide.

Authors:  M Pope; P A Marsden; E Cole; S Sloan; L S Fung; Q Ning; J W Ding; J L Leibowitz; M J Phillips; G A Levy
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals.

Authors:  T Akaike; Y Noguchi; S Ijiri; K Setoguchi; M Suga; Y M Zheng; B Dietzschold; H Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

9.  Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2).

Authors:  H Adler; J L Beland; N C Del-Pan; L Kobzik; J P Brewer; T R Martin; I J Rimm
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

10.  Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice.

Authors:  G Karupiah; J H Chen; S Mahalingam; C F Nathan; J D MacMicking
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  106 in total

1.  Gaseous Nitric Oxide and Dinitrosyl Iron Complexes with Thiol-Containing Ligands as Potential Medicines that Can Relieve COVID-19.

Authors:  A F Vanin; A V Pekshev; A B Vagapov; N A Sharapov; V L Lakomkin; A A Abramov; A A Timoshin; V I Kapelko
Journal:  Biophysics (Oxf)       Date:  2021-04-27

2.  [Pulmonary arterial hypertension and COVID-19].

Authors:  M L Avellanas Chavala
Journal:  Med Intensiva (Engl Ed)       Date:  2020-05-28

3.  Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN.

Authors:  Eric C Mossel; Bruno Sainz; Robert F Garry; C J Peters
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  Polyphosphate in Antiviral Protection: A Polyanionic Inorganic Polymer in the Fight Against Coronavirus SARS-CoV-2 Infection.

Authors:  Werner E G Müller; Xiaohong Wang; Meik Neufurth; Heinz C Schröder
Journal:  Prog Mol Subcell Biol       Date:  2022

5.  Nitric oxide is elicited and inhibits viral replication in pigs infected with porcine respiratory coronavirus but not porcine reproductive and respiratory syndrome virus.

Authors:  Kwonil Jung; Ashita Gurnani; Gourapura J Renukaradhya; Linda J Saif
Journal:  Vet Immunol Immunopathol       Date:  2010-04-01       Impact factor: 2.046

Review 6.  Sex differences in COVID-19: the role of androgens in disease severity and progression.

Authors:  Mohamed S Mohamed; Thiago C Moulin; Helgi B Schiöth
Journal:  Endocrine       Date:  2020-11-11       Impact factor: 3.633

7.  Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.

Authors:  Guoyao Wu; Cynthia J Meininger; Catherine J McNeal; Fuller W Bazer; J Marc Rhoads
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Mycobacterium tuberculosis whole cell lysate enhances proliferation of CD8 positive lymphocytes and nitric oxide secretion in the lungs of live porcine respiratory and reproductive syndrome virus vaccinated pigs.

Authors:  Cordelia Manickam; Varun Dwivedi; Jayla Miller; Tracey Papenfuss; Gourapura J Renukaradhya
Journal:  Viral Immunol       Date:  2013-01-11       Impact factor: 2.257

Review 9.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

10.  Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy.

Authors:  Arun K Ghosh; Kai Xi; Michael E Johnson; Susan C Baker; Andrew D Mesecar
Journal:  Annu Rep Med Chem       Date:  2007-02-01       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.